Literature DB >> 10435174

Efficacy of statin therapy: possible effect of phenytoin.

M J Murphy1, M H Dominiczak.   

Abstract

Statins are currently the most widely prescribed lipid-lowering drugs. Individual statins are known to be metabolised by the CYP3A4 isoform of the cytochrome P450 system. The effect of CYP3A4 inducers such as phenytoin on the metabolism and efficacy of these agents is unknown. We report a patient with familial hypercholesterolaemia and epilepsy in whom the introduction and subsequent discontinuation of phenytoin were associated with marked changes in the lipid response to treatment with simvastatin and atorvastatin. The serum activity of gamma-glutamyl transpeptidase may have acted as a marker of microsomal induction by phenytoin, since it rose markedly when phenytoin was introduced and returned to normal after it was discontinued.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435174      PMCID: PMC1741263          DOI: 10.1136/pgmj.75.884.359

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Statins and phenytoin interact - a case history.

Authors:  Kit Mun Tan; John G Kelly; Kathleen McGarry
Journal:  Br J Clin Pharmacol       Date:  2007-07-04       Impact factor: 4.335

2.  Frequency and clinical relevance of drug interactions with lovastatin and simvastatin: an observational database study.

Authors:  Tuire Tirkkonen; Anna Ryynänen; Tero Vahlberg; Kerttu Irjala; Timo Klaukka; Risto Huupponen; Kari Laine
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

5.  Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid.

Authors:  M Ucar; M Neuvonen; H Luurila; R Dahlqvist; P J Neuvonen; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2003-12-23       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.